2-(1H-Imidazol-1-yl)acetonitrile trifluoromethanesulfonate

Catalog No. :
ACWQNM067
CAS No. :
2259887-69-7
Molecular Formula :
C6H6F3N3O3S
Molecular Weight :
257.19

IUPAC Name:2-(1H-imidazol-1-yl)acetonitrile trifluoromethanesulfonate

2-(1H-Imidazol-1-yl)acetonitrile trifluoromethanesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$150.00Login to see priceIn stockIn stock
10g95%$223.00Login to see priceIn stockIn stock
25g95%$418.00Login to see priceIn stockInquiry
100g95%$1378.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1H-Imidazol-1-yl)acetonitrile trifluoromethanesulfonate
IUPAC Name2-(1H-imidazol-1-yl)acetonitrile trifluoromethanesulfonate
MDL No.0
Molecular FormulaC6H6F3N3O3S
Molecular Weight257.19
SMILESN#CCN1C=NC=C1.O=S(=O)(O)C(F)(F)F
InChI KeyACAQDOFOXJWTGR-UHFFFAOYSA-N
Synonym2-(1H-imidazol-1-yl)acetonitrile trifluoromethanesulfonate;2-(1-Imidazolyl)acetonitrile Trifluoromethanesulfonate
CAS No.2259887-69-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACWQNM067 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACWQNM067 route product structure diagram
    ACWQNM0672259887-69-7 In Stock
Inquiry

2. ACWQNM067 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACWQNM067 route product structure diagram
    ACWQNM0672259887-69-7 In Stock
Inquiry

Comments (0)